Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids

Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids

Lisa Lynn Dragic,1 Jeffrey Fudin,2–5 Michael E Schatman6,7 1Department of Pharmacy, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA; 2Department of Pharmacy, Albany Stratton VA Medical Center, Albany, NY, USA; 3Remitigate, LLC, Delmar, NY, USA; 4Albany College of Pharmacy...

Full description

Bibliographic Details
Main Authors:	Dragic LL, Fudin J, Schatman ME
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Journal of Pain Research
Subjects:	opioids opioid overdose doctors company safety prescribing trends alternative facts
Online Access:	https://www.dovepress.com/fact-or-fiction-the-truth-behind-the-doctors-company-claims-regarding--peer-reviewed-article-JPR

Similar Items

Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013–2017
by: Jamey J. Lister, et al.
Published: (2020-06-01)

The opioid crisis in North America: facts and future lessons for Europe
by: Kennedy Ayoo, et al.
Published: (2020-04-01)

Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data
by: William Bradford, et al.
Published: (2024-02-01)

Preventing opioid overdose with peer-administered naloxone: findings from a rural state
by: Bridget L. Hanson, et al.
Published: (2020-01-01)

Opioid overdose, interventions, and challenges
by: Samaneh Alaei, et al.
Published: (2022-05-01)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
by: Joy D Scheidell, et al.
Published: (2022-06-01)

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose
by: Matthew S. Ellis, et al.
Published: (2021-12-01)

Risk and protective factors for opioid overdose during the COVID-19 pandemic
by: J. Wong, et al.
Published: (2021-04-01)

Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions
by: Daniel M. Hartung, et al.
Published: (2022-01-01)

Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis
by: Shahin A. Saberi, et al.
Published: (2024-03-01)

Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions
by: Andrew S. Huhn, et al.
Published: (2018-02-01)

Editorial: Opioids and opioid-use disorders
by: Giordano de Guglielmo, et al.
Published: (2023-06-01)

Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series
by: Taylor A. Ochalek, et al.
Published: (2023-06-01)

Merging statewide data in a public/university collaboration to address opioid use disorder and overdose
by: William C. Becker, et al.
Published: (2021-01-01)

Opioid use and disposal patterns of emergency department patients
by: Valerie Hoerster, et al.
Published: (2023-01-01)

THE COVID-19 PANDEMIC AND THE OPIOID CRISIS IN UNITED STATES OF AMERICA
by: Muhammad Aadil, et al.
Published: (2021-03-01)

Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder
by: Sarah M. Bagley, et al.
Published: (2018-12-01)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City
by: Jake R. Morgan, et al.
Published: (2022-09-01)

The intersection of harm reduction and postoperative care for an illicit fentanyl consumer after major surgery: A case report
by: Salima S. J. Ladak, et al.
Published: (2021-01-01)

Psychostimulant drug co-ingestion in non-fatal opioid overdose
by: Siri Shastry, et al.
Published: (2024-03-01)

Superusers experiences in using naloxone to reverse opioid overdose - A qualitative study
by: K. Troberg, et al.
Published: (2022-06-01)

“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
by: Aurélie Aquizerate, et al.
Published: (2024-01-01)

Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions
by: Cao SS, et al.
Published: (2020-10-01)

Bilateral cerebellar hemorrhagic infarcts as an early presentation following opioid-induced toxic encephalopathy in an adult patient
by: Umer Ahmed, MS, BS, et al.
Published: (2021-05-01)

Sex differences in high opioid dose escalation among Malaysian patients with long term opioid therapy
by: Zin CS, et al.
Published: (2019-04-01)

Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy
by: Esposito DB, et al.
Published: (2020-01-01)

Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013
by: Janneke Berecki‐Gisolf, et al.
Published: (2017-02-01)

Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
by: Joe Schofield, et al.
Published: (2023-05-01)

Opioid Risk Mitigation Strategies and Overdose Resuscitation
by: Martin Klapheke, et al.
Published: (2017-08-01)

No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment – results from a natural experiment of policy change in Sweden
by: Anders Håkansson, et al.
Published: (2023-11-01)

‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis – Considerations, options and examples towards broad-based implementation
by: Benedikt Fischer, et al.
Published: (2020-11-01)

Editorial: The outbreak and sequelae of the increase in opioid use in the United States, Canada, and beyond
by: Samuel R. Friedman, et al.
Published: (2022-09-01)

Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial
by: Gabriela Cedillo, et al.
Published: (2022-05-01)

Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol
by: Amber Cragg, et al.
Published: (2017-12-01)

Predictors and prescribing patterns of opioid medications surrounding reverse shoulder arthroplasty
by: Vani J. Sabesan, MD, et al.
Published: (2020-12-01)

Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
by: Ciara A. Barr, et al.
Published: (2023-11-01)

Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
by: Kathryn G. Tippey, et al.
Published: (2019-03-01)

Life-threatening coma and full-thickness sunburn in a patient treated with transdermal fentanyl patches: a case report
by: Sindali Katia, et al.
Published: (2012-07-01)

Fentanyl-related overdose during incarceration: a comprehensive review
by: Eliana Kaplowitz, et al.
Published: (2021-05-01)

Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model
by: Hannah K. Knudsen, et al.
Published: (2023-11-01)